Ghazal Hariri

Ghazal Hariri, PhD, currently serves as Senior Scientist II at Laronde since September 2022, following a role as Investigator at CSL Seqirus from 2019 to September 2022, where development of lipid nanoparticle (LNP) delivery technology and mRNA vaccine formulations was a primary focus. Prior to that, Ghazal worked as a Senior Scientist at Pfizer from 2016 to 2019, specializing in the design and development of polymer nanoparticle formulations for preclinical studies in various therapeutic areas. Academic credentials include a Doctor of Philosophy (Ph.D.) in Chemical and Physical Biology and a Master's Degree in Bioengineering and Biomedical Engineering from Vanderbilt University, alongside a Bachelor's Degree in Chemical Engineering from Rose-Hulman Institute of Technology.